About this article. Written and edited by the Behavioral Health Rehab editorial team, which has covered addiction treatment, mental health services, and the behavioral health industry for more than a decade. Every statistic below is traced to a named federal or peer-reviewed source and linked in the References section.
Last updated July 2026, using the most recent federal data available at the time of writing. This is consumer education, not a clinical assessment. It has not been reviewed by a licensed clinician, and it does not endorse or rank any specific facility.
Why the Questions You Ask Before Choosing a Treatment Center Matter More Than the Photos on the Website
Almost nobody researches rehab under calm conditions. The call usually happens after something broke — an overdose, an arrest, a relationship ending, a doctor finally saying the word out loud. Decisions get made in a few days, often by an exhausted family member reading marketing pages at two in the morning.
That is exactly the environment in which bad choices happen. Treatment centers in the United States vary enormously in quality, staffing, and honesty, and the ones with the glossiest photography are not reliably the ones with the best clinical care. Amenities photograph well. Staffing ratios and medication policies do not.
The five questions below are the ones that separate a program worth your money and your life from one that is selling a stay. Each has a version of the answer you want to hear, a version that should worry you, and — importantly — a way to verify the answer yourself rather than taking the admissions line on faith.
The 2026 Reality of Addiction and Mental Health Treatment Access in the United States, According to Federal Survey Data
Context helps explain why so many people end up in a program that is a poor fit. The Substance Abuse and Mental Health Services Administration's most recent National Survey on Drug Use and Health covers calendar year 2024 and remains the current federal benchmark. Its central finding is blunt: of the roughly 52.6 million people aged 12 or older who needed substance use treatment that year, only about 10.2 million received any. SAMHSA summarized it as an 80 percent treatment gap.
Substance use treatment need versus treatment received, 2024
Needed treatment but did not receive it — about 80%
Received substance use treatment — about 20%
Medication for opioid use disorder among people with past-year OUD, 2024
Received medication for opioid use disorder — 17.0%
Did not receive medication for opioid use disorder — 83.0%
Source: SAMHSA, 2024 National Survey on Drug Use and Health, released July 2025. Of the 4.8 million people aged 12 or older with a past-year opioid use disorder, roughly 818,000 received medication for it.
Two more figures from the same survey are worth keeping in your head. About 48.4 million Americans aged 12 or older met criteria for a substance use disorder in 2024. Among the 61.5 million adults with any mental illness, just over half — 52.1 percent — received any mental health treatment in the past year.
None of this means treatment does not work. It means the system is under-supplied, unevenly regulated, and full of programs competing hard for a small number of paying admissions. Asking sharp questions is not rude. It is the only realistic form of consumer protection available to you.
Question One: Is This Treatment Center Licensed by the State and Independently Accredited, and Can I Verify That Myself Without Taking Your Word for It?
Start here, because everything else depends on it. Licensing and accreditation are two different things, and programs sometimes blur the line on purpose.
State licensure is mandatory. It is issued by the state agency that oversees behavioral health facilities, and it defines what level of care the program is legally permitted to provide. A facility licensed only as an outpatient clinic cannot lawfully run a medical detox, no matter what its website implies.
Accreditation is voluntary, and it comes from independent nonprofits — most commonly The Joint Commission or CARF International. Accreditation involves outside surveyors reviewing clinical records, safety protocols, staffing, and outcome tracking. It is not a guarantee of quality, but its absence in a program charging tens of thousands of dollars is a question worth pressing.
The verification step is the part most families skip. SAMHSA maintains FindTreatment.gov, a free federal locator built from its inventory of licensed facilities, and both The Joint Commission and CARF publish searchable directories of the organizations they have accredited. If a program tells you it is accredited and you cannot find it in the accreditor's own database, that discrepancy is the answer.
Worth knowing: "Certified," "approved," and "recognized" are not regulated terms in treatment marketing. Ask specifically: licensed by which state agency, at what level of care, and accredited by whom, under what name? Then check both, independently.
Question Two: Which Specific Evidence-Based Treatments Do You Actually Deliver, and Do You Offer Medications for Opioid and Alcohol Use Disorder On Site?
"Evidence-based" appears on nearly every treatment center website in the country. It costs nothing to write. The useful question is which therapies, delivered by whom, how often, and for how long.
A credible program will name them without hesitating: cognitive behavioral therapy, dialectical behavior therapy, motivational interviewing, contingency management, trauma-focused approaches such as EMDR, family therapy. It will also tell you how many individual sessions per week you actually get, which is often a much smaller number than the brochure implies once you subtract group time, meals, and unstructured hours.
The medication question is where a lot of programs quietly disqualify themselves. The National Institute on Drug Abuse is unambiguous that medications are an essential element of treatment for opioid use disorder, and effective medications exist for alcohol use disorder as well. Yet a meaningful number of residential programs still decline to offer them, sometimes on philosophical grounds. If someone is being treated for opioid use disorder in a program that will not provide buprenorphine, methadone, or naltrexone, and will not coordinate with a provider who does, you should know that before admission rather than after.
The gap is starkest for young people. Analysis of federal treatment admissions data published in Health Affairs found medications for opioid use disorder were included in only 9.5 percent of adolescent opioid-related treatment admissions, compared with 36.4 percent of adult admissions.
Medications for opioid use disorder included in opioid-related treatment admissions
Adults — 36.4%
Adolescents (ages 12–17) — 9.5%
Source: analysis of the 2022 Treatment Episode Data Set–Admissions, published in Health Affairs (2025). The same analysis found only 30.8 percent of adolescents with opioid use disorder received any past-year substance use treatment.
If the therapies themselves are unfamiliar territory, our overview of the top evidence-based therapies for behavioral health recovery explains what each approach is designed to do.
Question Three: Who Exactly Will Be Treating Me, What Are Their Credentials, and Who Is Physically On Site Overnight and on Weekends?
Websites show a medical director. They rarely show the staffing ratio at 3 a.m. on a Sunday.
Ask for the roles, not the philosophy. Is there a physician or psychiatric prescriber, and how often are they actually on site rather than on call? Are the therapists licensed independently, or are they associates under supervision? Is nursing coverage continuous, or does it end at a certain hour? What is the ratio of clinical staff to clients, and does that number include support staff and technicians, because plenty of programs pad it that way.
Two follow-ups are worth asking outright. First: what is your staff turnover like? High churn is a reliable predictor of inconsistent care, and honest programs will tell you. Second: who handles a psychiatric emergency or a medical complication, and where is the nearest hospital? Detox in particular can be dangerous. Alcohol and benzodiazepine withdrawal can be fatal without medical supervision, and a program offering "detox" without appropriate medical staffing is a serious hazard rather than a bargain.
Co-occurring conditions raise the stakes further. If someone has both a substance use disorder and a psychiatric diagnosis, a program without a psychiatric prescriber is not equipped to treat them, whatever it says about dual diagnosis. That interaction is covered more fully in our guide to understanding dual diagnosis.
Question Four: What Is the Total Cost in Writing, What Will My Insurance Actually Pay, and What Happens Financially If I Leave Treatment Early?
Get the number in writing. Not a range, not "we'll work with you," not a per-day figure that conveniently omits labs, medication, psychiatric consults, and the assessment fee.
Under federal parity rules — the Mental Health Parity and Addiction Equity Act, administered in part by the Centers for Medicare & Medicaid Services — health plans that cover behavioral health generally cannot impose financial requirements or treatment limits on it that are more restrictive than those applied to comparable medical and surgical care. That protection is real, but it does not mean everything is free, and it does not stop a facility from being out of network.
Questions that reliably surface trouble:
- Are you in network with my plan, or are you billing out of network and telling me not to worry about it?
- What is my expected out-of-pocket total, including deductible, coinsurance, and any services billed separately?
- What happens if my insurer denies continued stay after a week? Do I owe the balance?
- Is there a refund policy if I leave early, and is it in the admission agreement?
- Are lab or urine drug screens billed separately, and by whom?
The last one is not trivial. Excessive urine drug testing billed at inflated rates has been a persistent problem in this industry. A program that cannot explain its own billing clearly is either disorganized or hoping you will not look. Insurance mechanics are broken down further in our piece on which behavioral health disorders are covered by insurance for treatment.
Question Five: What Happens After I Discharge, and How Do You Actually Measure Whether Your Program Works?
Thirty days of residential treatment is not a cure, and any program that frames it that way is misleading you. The period immediately after discharge carries elevated risk, particularly for opioid use disorder, because tolerance drops during abstinence while the drug supply outside has not gotten any safer.
So ask what the plan is. A serious answer includes a named step-down level of care, a scheduled first appointment before you leave rather than a phone number to call later, medication continuity with a prescriber who exists, and some form of ongoing contact. Recovery housing, peer support, and family involvement all belong in that conversation.
Then ask the harder question: how do you know your program works? Success rates quoted in treatment marketing are almost universally unverifiable, and there is no federal standard forcing accuracy. What you are listening for is not a big number. It is whether the program can tell you honestly how it defines success, how long it follows people, what percentage it loses track of, and whether anyone outside the organization has audited that. A program that says "we don't have rigorous long-term outcome data, here's what we do track" is being more trustworthy than one quoting a 90 percent success rate it cannot substantiate.
A Quick Reference Table: What a Strong Answer Sounds Like and Where You Can Independently Verify It
| Question | What a strong answer sounds like | How to verify it |
|---|---|---|
| Licensing and accreditation | Names the state agency, the license level, and the accreditor | FindTreatment.gov; accreditor's own public directory |
| Treatments offered | Names specific therapies and session frequency; offers or coordinates medication | NIDA and SAMHSA treatment guidance |
| Staffing | Gives roles, licenses, overnight coverage, and a real client-to-clinician ratio | State license verification portals for individual clinicians |
| Cost and insurance | Written estimate, network status, refund and early-discharge terms | Call your insurer directly; get a reference number |
| Aftercare and outcomes | Named step-down plan, appointment booked before discharge, honest outcome limits | Ask for the discharge planning policy in writing |
One More Question That Became Far More Important in 2026: What Happens to My Substance Use Treatment Records and Who Can See Them?
This one is new enough that many admissions staff are still catching up on it.
Federal confidentiality rules for substance use disorder records, known as 42 CFR Part 2, were substantially rewritten to align more closely with HIPAA. The final rule took effect in April 2024 with a long runway, and the compliance date was February 16, 2026. From that date, the HHS Office for Civil Rights began accepting complaints and enforcing the regulation directly, with civil monetary penalties available.
What this means in practice: programs subject to Part 2 must now give you an updated notice explaining how your substance use records may be used and disclosed. A single patient consent can now cover future uses for treatment, payment, and health care operations, which makes care coordination easier — and also means the consent form you sign at intake is doing considerably more work than it used to. The rule preserves the long-standing protection that these records generally cannot be used against you in civil, criminal, administrative, or legislative proceedings without your written consent or a court order.
So read the form. Ask what you are consenting to, who receives your information, and whether you can limit it. A program that gets visibly impatient with that question has told you something useful about how it treats patients.
Warning Signs and Red Flags That Should Make You Slow Down Before Admitting to Any Rehab Program
| Red flag | Why it matters |
|---|---|
| Guaranteed success rates or promises of a cure | No credible program can guarantee an outcome. Substance use disorder is a chronic, relapsing condition. |
| Offers of free travel, free rent, or cash incentives to enroll | Paying for referrals is a federal crime under the Eliminating Kickbacks in Recovery Act. It signals patient brokering. |
| Pressure to admit today, before you can compare options | Genuine urgency exists, but high-pressure sales tactics are about filling a bed, not clinical need. |
| Refusal to provide written costs or a copy of the admission agreement | You cannot consent to terms you have not been allowed to read. |
| Refusal to offer or coordinate medication for opioid use disorder | Conflicts with federal treatment guidance and materially raises overdose risk after discharge. |
| Vague answers about who owns and operates the facility | The website you found may be a marketing intermediary, not the program itself. |
That last point deserves emphasis. A large share of the pages ranking for treatment searches are lead-generation sites rather than facilities. If the phone number connects you to someone who will not name the specific facility you would be admitted to, you are speaking to a broker.
What Even the Best Questions Cannot Tell You, and Where the Limits of Consumer Research Honestly Sit
Asking well does not guarantee a good outcome. Accreditation can coexist with poor culture. A well-staffed program can still be the wrong fit. And for many people the binding constraint is not information at all — it is that the nearest appropriate program is two hundred miles away, has a waiting list, and does not take their insurance. The 80 percent treatment gap is not primarily a research failure by patients.
A few other honest caveats. Level of care matters more than brand: for many people, intensive outpatient treatment while living at home outperforms an expensive residential stay, and a program that recommends its own most expensive option to every caller is not assessing anyone. Cost does not track quality in this industry with any reliability. And no article, including this one, can substitute for an assessment by a qualified clinician who has actually met the person.
If you are still mapping the landscape — levels of care, program types, who provides what — our overviews of behavioral health treatment explained and the different types of behavioral health rehab cover the structure, and our behavioral health and recovery resource guide lists public and academic sources worth reading directly.
If you or someone you know is in crisis
The 988 Suicide and Crisis Lifeline offers free, confidential support 24 hours a day. Call or text 988. For treatment referrals and information about mental health or substance use, the SAMHSA National Helpline is 1-800-662-HELP (4357). In a life-threatening emergency, call 911.
Disclaimer. This article is general educational information for people researching treatment options. It is not medical, clinical, legal, or financial advice, and it does not create a provider relationship. Licensing rules, insurance terms, and federal regulations change over time. Verify current requirements with the relevant state agency, your insurer, and a qualified clinician before making a treatment decision.
References and Citations
- Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024
- Substance Abuse and Mental Health Services Administration. SAMHSA Releases Annual National Survey on Drug Use and Health (press announcement, July 28, 2025). https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health
- Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS): 2024 Data on Substance Use and Mental Health Treatment Facilities. https://www.samhsa.gov/data/report/2024-n-sumhss-annual-report
- Substance Abuse and Mental Health Services Administration. FindTreatment.gov. https://findtreatment.gov/
- U.S. Department of Health and Human Services, Office for Civil Rights. Fact Sheet: 42 CFR Part 2 Final Rule (compliance date February 16, 2026). https://www.hhs.gov/hipaa/for-professionals/regulatory-initiatives/fact-sheet-42-cfr-part-2-final-rule/index.html
- U.S. Department of Health and Human Services. Understanding Confidentiality of Substance Use Disorder (SUD) Patient Records ("Part 2"). https://www.hhs.gov/hipaa/part-2/index.html
- National Institute on Drug Abuse. Principles of Effective Treatment and Medications to Treat Opioid Use Disorder. https://nida.nih.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/principles-effective-treatment
- Health Affairs (2025). Fewer Than 1 In 3 Adolescents With Past-Year Opioid Use Disorder Received Substance Use Treatment, 2022–23. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.00240
- Centers for Medicare & Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
- The Joint Commission. Behavioral Health Care and Human Services Accreditation. https://www.jointcommission.org/en-us/accreditation-and-certification/health-care-settings/behavioral-health-care
- CARF International. Accreditation for Behavioral Health Providers. https://carf.org/
- Eliminating Kickbacks in Recovery Act of 2018, 18 U.S.C. § 220. https://www.law.cornell.edu/uscode/text/18/220
- 988 Suicide & Crisis Lifeline. https://988lifeline.org/